Patrick M. Sweeney & Associates’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$490K Buy
1,162
+4
+0.3% +$1.59K 0.28% 89
2026
Q2
$419K Buy
1,158
+50
+5% +$17.1K 0.24% 104
2026
Q1
$390K Hold
1,108
– – 0.25% 102
2025
Q4
$363K Buy
1,108
+71
+7% +$22.5K 0.23% 105
2025
Q3
$293K Buy
1,037
+62
+6% +$18K 0.19% 125
2025
Q2
$291K Hold
975
– – 0.2% 120
2025
Q1
$304K Hold
975
– – 0.23% 110
2024
Q4
$254K Sell
975
-16
-2% -$4.75K 0.19% 124
2024
Q3
$319K Hold
991
– – 0.23% 111
2024
Q2
$310K Hold
991
– – 0.25% 99
2024
Q1
$282K Buy
991
+66
+7% +$19.3K 0.23% 105
2023
Q4
$266K Buy
+925
New +$252K 0.24% 96

Other funds holding AMGN

Patrick M. Sweeney & Associates's AMGN Position: Q3 2026 in Review

Patrick M. Sweeney & Associates increased its Amgen (AMGN) stake by 0.35% in Q3 2026, buying an estimated $1.59K and bringing the position to 1,162 shares worth $490K. The position accounts for 0.28% of the portfolio, ranked #89.

Patrick M. Sweeney & Associates first reported a position in AMGN in Q4 2023 and has held it in 12 quarters since. 2,024 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Patrick M. Sweeney & Associates held 1,162 shares of Amgen worth $490K as of Q3 2026.
  • Patrick M. Sweeney & Associates bought 4 Amgen shares in Q3 2026, an estimated $1.59K.
  • Amgen made up 0.28% of Patrick M. Sweeney & Associates's portfolio in Q3 2026, its #89 holding.
  • Patrick M. Sweeney & Associates first reported a position in Amgen in Q4 2023 and has held it in 12 quarters since.
  • 2,024 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Patrick M. Sweeney & Associates's 13F filing for Q3 2026, filed 22 Oct 2026.